B. A. Alsfouk

发表

Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2

Wagdy M. Eldehna, I. Eissa, Ahmed B. M. Mehany, 2022, Molecules.

Synthesis and Biological Evaluation of Imadazo[1,2-a]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus

Ebtehal S. Al-Abdullah, N. Altwaijry, E. S. Al-Abdullah, 2022, Pharmaceuticals.

In Silico Prospects and Therapeutic Applications of Ouabagenin and Hydroxylated Corticosteroid Analogues in the Treatment of Lung Cancer

S. Ejaz, F. Alharbi, Mubashira Aziz, 2022, Applied Biochemistry and Biotechnology.

Distance Education During COVID-19 Pandemic: A College of Pharmacy Experience

N. Altwaijry, A. Ibrahim, B. A. Alsfouk, 2021, Risk management and healthcare policy.

RMHP_A_308998 2099..2110

N. Altwaijry, A. Ibrahim, B. A. Alsfouk, 2021 .

Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6″-O-acetyl)-Glucoside from Calligonum tetrapterum

W. Dehaen, I. Eissa, A. Metwaly, 2022, Plants.

The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula, against SARS-CoV-2

I. Eissa, Abdulrahman M. Saleh, A. Mostafa, 2022, Plants.

In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivative

Ibrahim M. Ibrahim, I. Eissa, Ahmed B. M. Mehany, 2022, Journal of biomolecular structure & dynamics.

Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway

Wagdy M. Eldehna, N. El-Deeb, I. Eissa, 2022, PloS one.

Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects

Ibrahim M. Ibrahim, I. Eissa, A. Metwaly, 2022, Molecules.

Synthesis, biological evaluation and computational investigations of S-benzyl dithiocarbamates as the cholinesterase and monoamine oxidase inhibitors

A. Saeed, I. Orhan, P. A. Channar, 2022, Journal of Molecular Structure.

Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study

Y. Hassan, A. A. Mohamed, A. A. El-Kholy, 2021 .

In Silico Prospects and Therapeutic Applications of Ouabagenin and Hydroxylated Corticosteroid Analogues in the Treatment of Lung Cancer

S. Ejaz, F. Alharbi, Mubashira Aziz, 2022, Applied Biochemistry and Biotechnology.

Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies.

Wagdy M. Eldehna, N. El-Deeb, I. Eissa, 2023, Journal of biomolecular structure & dynamics.

The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach

M. M. Khalifa, I. Eissa, A. Metwaly, 2022, Metabolites.

A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study

Ibrahim M. Ibrahim, I. Eissa, A. Metwaly, 2023, Life.

Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy

Ebtehal S. Al-Abdullah, N. Altwaijry, E. S. Al-Abdullah, 2021, Monatshefte für Chemie - Chemical Monthly.

Neurodevelopmental outcomes in children exposed prenatally to levetiracetam

B. A. Alsfouk, 2022, Therapeutic advances in drug safety.

Patterns of antiseizure medication prescription in pregnancy and maternal complications in women with epilepsy: A retrospective study in Saudi Arabia

Abdulaziz Alsemari, S. Alageel, B. A. Alsfouk, 2022, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy.

P. Kwan, M. Brodie, M. Walters, 2020, JAMA neurology.

Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease

W. Dehaen, I. Eissa, C. Arenz, 2022, Molecules.

Antiseizure medications use during pregnancy and congenital malformations: A retrospective study in Saudi Arabia

Abdulaziz Alsemari, S. Alageel, B. A. Alsfouk, 2021, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches

Ashwag S Alanazi, N. Altwaijry, B. A. Alsfouk, 2023, Pharmaceuticals.

Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30‐year cohort study

M. Brodie, Zhibin Chen, Patrick S L Kwan, 2023, Epilepsia.

Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs

I. Eissa, Abdulrahman M. Saleh, A. Metwaly, 2022, Molecules.

Characteristics and treatment outcomes of newly diagnosed epilepsy in older people: A 30‐year longitudinal cohort study

P. Kwan, M. Brodie, M. Walters, 2020, Epilepsia.

New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story

N. El-Deeb, I. Eissa, A. Metwaly, 2023, Journal of Molecular Structure.

Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2

Ibrahim M. Ibrahim, I. Eissa, A. Metwaly, 2023, RSC advances.